Two cases of malignant melanoma that responded to switching small－molecule target drugs and immune checkpoint inhibitors appropriately after surgery

Authors :: Takayuki Suyama
Tomoo Fukuda
Yoshiki Sato
Megumi Yokoyama
Aya Takahashi
Ryokichi Taguchi
Source :: Skin Cancer. 34:209-214
Publication Year :: 2019
Publisher :: The Japanese Skin Cancer Society, 2019.

Subjects :: business.industry
Melanoma
Immune checkpoint inhibitors
medicine
Cancer research
medicine.disease
business
Small molecule

Tools